Andean Precious Metals Corp. (CVE:APM – Get Free Report) Senior Officer Juan Carlos Sandoval Amare acquired 31,300 shares of the firm’s stock in a transaction dated Friday, January 3rd. The stock was bought at an average price of C$1.21 per share, with a total value of C$37,860.48.
Andean Precious Metals Trading Up 2.6 %
Shares of APM opened at C$1.20 on Wednesday. The company’s fifty day simple moving average is C$1.35 and its 200 day simple moving average is C$1.26. Andean Precious Metals Corp. has a 1-year low of C$0.57 and a 1-year high of C$2.18. The company has a market cap of C$179.23 million, a price-to-earnings ratio of 3.16 and a beta of 1.22.
Wall Street Analysts Forecast Growth
Separately, Desjardins raised Andean Precious Metals to a “moderate buy” rating in a research report on Thursday, October 31st.
About Andean Precious Metals
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.
Featured Articles
- Five stocks we like better than Andean Precious Metals
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- 5 Top Rated Dividend Stocks to Consider
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- How to Invest in Insurance Companies: A Guide
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Andean Precious Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andean Precious Metals and related companies with MarketBeat.com's FREE daily email newsletter.
